Role of anti-vimentin antibodies in allograft rejection
Open Access
- 1 November 2013
- journal article
- review article
- Published by Elsevier in Human Immunology
- Vol. 74 (11) , 1459-1462
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Expression of vimentin and high‐molecular‐weight cytokeratin (clone 34ßE12) in differentiating reactive renal tubular cells from low‐grade urothelial carcinoma cells in voided urineCytopathology, 2011
- Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathyThe Journal of Heart and Lung Transplantation, 2010
- Expression of Nestin, Vimentin, and NCAM by Renal Interstitial Cells after Ischemic Tubular InjuryJournal of Biomedicine and Biotechnology, 2010
- Identification of Non-HLA Antigens Targeted by Alloreactive Antibodies in Patients Undergoing Chronic HemodialysisJournal of Proteome Research, 2010
- Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factorJournal of Leukocyte Biology, 2007
- The Original Pathologische Anatomie Leiden-Endothelium Monoclonal Antibody Recognizes a Vascular Endothelial Growth Factor–Binding Site within Neuropilin-1Cancer Research, 2007
- Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritisArthritis & Rheumatism, 2007
- Autoantibodies to Vimentin Cause Accelerated Rejection of Cardiac AllograftsThe American Journal of Pathology, 2007
- Molecular identification of PAL-E, a widely used endothelial-cell markerBlood, 2005
- Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2Blood, 2003